期刊文献+

利用甲基化特异性PCR检测孕妇血浆中胎源性RASSF1A片段

To explore of the methylated indentifying PCR to detecte the free fetal DNA in maternal plasma
原文传递
导出
摘要 目的探索母胎差异甲基化位点RASSF1A在孕妇血浆胎儿DNA检测中的价值。方法收集126例孕妇血浆,同时收集外周血细胞及胎盘(或绒毛)组织,利用甲基化特异性PCR(MSP)分析母胎间RASSF1A基因甲基化状态的差异,并评估孕妇血浆中高甲基化RASSF1A片段的检出率。结果证实RASSF1A基因在母体外周血细胞呈现低甲基化状态,而在胎盘或绒毛组织中呈高甲基化状态,且这种甲基化差异在不同孕期均稳定存在。采用MSP技术对孕妇血浆胎源性RASSF1A基因的的检出率为86.5%。结论高甲基化RASSF1A基因可作为孕妇血浆中胎源DNA的标志物,有望为利用孕妇血浆胎儿DNA进行无创性产前诊断开辟新的方向。 Objective: To explore the value of differentially methylated RASSF1A in indentifying free fetal DNA in maternal plasma.Methods: Maternal plasma was collected from 126 singleton pregnancies,placental or chorionic villi tissues were also obtained.Methylation specific PCR(MSP) was employed to analyze the maternal-fetal methylation differences of RASSF1A.Results: It was confirmed that RASSF1A were hypomethylated in maternal blood cells but hypermethylated in placental or chorionic villi tissues.Moreover,the differential methylation for RASSF1A could be seen during the whole pregnant period.Using MSP,the detection rate of fetal RASSF1A in maternal plasma was 86.5%.Conclusion: Hypermethylated RASSF1A was a fetal-specific marker which can be used in identifying fetal DNA in maternal plasma.
出处 《中国优生与遗传杂志》 2013年第8期76-77,82,共3页 Chinese Journal of Birth Health & Heredity
基金 湖北省卫生厅青年科技人才基金编号:QJX2008-28
关键词 胎儿DNA 差异甲基化 RASSF1A 无创性产前诊断 Fetal DNA Differential methylation RASSF1A Noninvasive prenatal diagnosis
  • 相关文献

参考文献9

  • 1Bustamante - Aragones A, Gonzalez - Gonzalez C, de Alba MR, et al. Noninvasive prenatal diagnosis using cffDNA in maternal blood: state of the art[ J]. Expert Rev Mol Diagn, 2010, 10 (2) : 197 - 205.
  • 2Puszyk WM, Crea F, Old RW. Noninvasive prenatal diagnosis of aneuploidy using cell - free nucleic acids in maternal blood : promises and unanswered questions [ J]. Prenat Diagn, 2008, 28 ( 1 ) : 1 - 6.
  • 3Bellido ML, Radpour R, Lapaire O, et al. MALDI -TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma[ J ]. Biol Reprod, 2010, 82 (4) : 745 - 750.
  • 4Chu T, Burke B, Bunce K,et al. A microarray- based approach for the identification of epigenetic biomarkers for the noninvasive diagno- sis of fetal disease[J]. Prenat Diagn, 2009, 29(11 ): 1020 -1030.
  • 5Tsui DW, Lam YM, Lee WS, et al. Systematic identification of pla- cental epigenetic signatures for the noninvasivc prenatal detection of Edwards syndrome[ J]. PLoS One, 2010 Nov 30, 5 ( 11 ) : e15069.
  • 6Chiu RW, Chim SS, Wong IH, et al. Hypermethylation of RASSF1A in human and rhesus placentas[ J ]. Am J Pathol, 2007, 170 ( 3 ) : 941 - 950.
  • 7Old RW, Crea F, Puszyk W, et al. Candidate epigenetic biomarkers for non - invasive prenatal diagnosis of Down syndrome [ J ]. Reprod Biomed Online, 2007,15 ( 2 ) : 227 - 235.
  • 8Huang Q, Baum L, Huang JF, et al. Isolation and enrichment of hu- man genomic CpG islands by methylation - sensitive mirror orientation selection[ J]. Anal Biochem, 2007, 365(2) : 153 - 164.
  • 9Tang DL, Li Y, Zhou X, et al. Multiplex fluorescent PCR for nonin- vasive prenatal detection of fetal - derived paternally inherited disea- ses using circulatory fetal DNA in maternal plasma[ J]. Eur J Obstet Gynecol Reprod Biol, 2009, 144 ( 1 ) : 35 - 39.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部